GUO, JUNQING,HART, AMY C.,MACOR, JOHN E.,MERTZMAN, MICHAEL E.,PITTS, WILLIAM J.,SPERGEL, STEVEN H.,WATTERSON, SCOTT HUNTER,ANDAPPAN MURUGAIAH SUBBAIAH, MURUGAIAH,CHEN, JIE,DZIERBA, CAROLYN DIANE,LUO,
申请号：
CA3053484
公开号：
CA3053484A1
申请日:
2018.02.12
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
Compounds having formula (I) (IX), and enantiomers, and diastereomers, stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein: (I), (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).
